What is McKie Splints?
McKie Splints designs and manufactures therapeutic splinting devices for a variety of conditions affecting the thumb, wrist, and hand, including arthritis, cerebral palsy, and post-stroke rehabilitation. Their product portfolio features bio-mechanically engineered neoprene thumb splints, custom hand wrist splints, and accessories available in multiple sizes for all age groups. The company is recognized by healthcare professionals and institutions for its commitment to enhancing hand functionality through innovative orthopedic solutions. McKie Splints also provides educational resources, such as webinars, for occupational and physical therapy teams to highlight the advantages of their specialized products.
How much funding has McKie Splints raised?
McKie Splints has raised a total of $26K across 1 funding round:
Debt
$26K
Debt (2021): $26K with participation from PPP
Key Investors in McKie Splints
PPP
Public-Private Partnership
What's next for McKie Splints?
With the recent substantial expansion capital, McKie Splints is poised for significant growth. This funding is expected to accelerate product development, enhance manufacturing capabilities, and broaden market reach. The company's strategic focus on therapeutic splinting devices for conditions like arthritis and post-stroke recovery positions it well to capitalize on the increasing demand for rehabilitation technology and specialized orthopedic aids. Future initiatives may include expanding their product line, entering new geographical markets, and forging stronger partnerships within the healthcare sector to further empower users in improving their hand functionality.
See full McKie Splints company page